Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

MCC: ADRs to ATT

  1. Home
  2. MCC: ADRs to ATT
  • Adverse Drug Reactions [ADRs]

    H5Content
  • Types of ADR of TB Treatment

    H5Content
  • Management of Adverse Drug Reactions [ADRs] of TB Treatment

    H5Content
  • Pharmacovigilance in NTEP

    H5Content
  • Possible Adverse Events Due to Drugs in Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen

    H5Content
  • Adverse Drug Reactions due to Longer oral M/XDR-TB Regimen

    H5Content
  • Adverse Drug Events: H Mono/Poly DR-TB Regimen

    H5Content
  • ADRs to Second Line Treatment

    H5Content
  • Management of ADR: Rash, Allergy and Anaphylaxis Reaction

    H5Content
  • Management of DR-TB ADR: Gastritis, abdominal pain

    H5Content
  • Management of DR-TB ADR: Diarrhoea and/or Flatulence

    H5Content
  • Management of DR-TB ADR: Hepatitis

    H5Content
  • Management of DR-TB ADR: Giddiness

    H5Content
  • Management of DR-TB ADR: QT Prolongation

    H5Content
  • Management of DR-TB ADR: Hematological Abnormalities

    H5Content
  • Management of DR-TB ADR: Hypothyroidism

    H5Content
  • Management of DR-TB ADR: Arthralgia

    H5Content
  • Management of DR-TB ADR: Peripheral Neuropathy

    H5Content
  • Management of DR-TB ADR: Psychotic Symptoms

    H5Content
  • Management of DR-TB ADR: Nephrotoxicity [Renal Toxicity]

    H5Content
  • Management of DR-TB ADR: Vestibular Toxicity

    H5Content
Cover

MCC: ADRs to ATT

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International